St. Jude Outlines Strategy To Revive Pacemaker Business

St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.

More from Archive

More from Medtech Insight